EUCTR2009-018064-95-BE进行中（未招募）1 期
Amyloid imaging in late life depression
niversity of Leuven0 个研究点目标入组 120 人开始时间: 2012年5月22日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. older than 60 years
- •2. a mjor depressive disorder according to DSM IV criteria
- •3. a MMSE> ou = 20
- •4. not primarily referred for assessment of cognitive impairment
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 100
排除标准
- •1. anothermajor psychiatric illness
- •2. alcohol or drug dependence
- •3. neurologic illness, including stroke, transient ischemic attacks and dementia
- •4. illness or medication precluding cognitive testing
- •5. metal implants precluding MRI. Information on prior episodes and age of onset will be obtained from patients and from caregivers.
- •6. ECT in the last 3 months prior to inclusion.
- •7. Use of steroids within the last 3 months or other medication interfering with HPA axis.
研究者
相似试验
进行中（未招募）
不适用
Amyloid Imaging in Alzheimer´s diseaseImaging amyloid plaques in patients with probable Alzheimer´s disease using [11C]PIB and [18F]FDDNP PETEUCTR2007-000148-28-ATDepartment of Neurology, Medical University of Vienna
未知
不适用
euroimaging study for late-life depressiolate-life depressionJPRN-UMIN000001228ational Institute of Radiological Sciences60
已完成
不适用
Amyloid PET imaging study for dimenting disordersdementing disorderJPRN-UMIN000028758Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama20
已完成
不适用
Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP)ElderlyMajor DepressionNCT01962753University Hospital, Tours92
进行中（未招募）
1 期
Determine the value of the compound [18F]-AV45, which is usable for visualization of the build-up of the amyloid protein in brains of memory clinic patients, in making a diagnosis in patients of the memory outpatient clinic.The total number of inclusion in this study is 170 subjects140 patients (including Alzheimer’s disease (AD) patients, patients with mild cognitive impairment (MCI), patients with subjective memory complaints (SMC), patients with other neurodegenerative diseases and 30 cognitively normal volunteers.EUCTR2012-001599-12-NLVU University Medical Center (VUmc)170